These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33556948)

  • 21. Individualized Perioperative Blood Pressure Management for Adult Moyamoya Disease: Experience from 186 Consecutive Procedures.
    Li C; Zhang N; Yu S; Xu Y; Yao Y; Zeng M; Li D; Xia C
    J Stroke Cerebrovasc Dis; 2021 Jan; 30(1):105413. PubMed ID: 33160127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalcoholic fatty liver disease is an independent risk factor for ischemic stroke after revascularization in patients with Moyamoya disease: a prospective cohort study.
    Zhang B; Li J; Zeng C; Tao C; He Q; Liu C; Zheng Z; Zhao Z; Mou S; Sun W; Wang J; Zhang Q; Wang R; Zhang Y; Ge P; Zhang D
    Lipids Health Dis; 2024 Mar; 23(1):80. PubMed ID: 38494486
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative Functional Outcomes and Prognostic Factors in Two Types of Adult Moyamoya Diseases.
    Zhang M; Tang J; Liu N; Xue Y; Ren X; Fu J
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104846. PubMed ID: 32439351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple Burr-Hole Surgery for the Treatment of Moyamoya Disease and Quasi-Moyamoya Disease in Children: Preliminary Surgical and Imaging Results.
    Mirone G; Cicala D; Meucci C; d'Amico A; Santoro C; Muto M; Cinalli G
    World Neurosurg; 2019 Jul; 127():e843-e855. PubMed ID: 30954732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low flow velocity in the middle cerebral artery predicting infarction after bypass surgery in adult moyamoya disease.
    Cho H; Jo KI; Yu J; Yeon JY; Hong SC; Kim JS
    J Neurosurg; 2017 May; 126(5):1573-1577. PubMed ID: 27257840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posterior cerebral artery stenosis and posterior circulation revascularization surgery in pediatric patients with moyamoya disease.
    Kimiwada T; Hayashi T; Shirane R; Tominaga T
    J Neurosurg Pediatr; 2018 Jun; 21(6):632-638. PubMed ID: 29624146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postoperative Symptomatic Cerebral Infarction in Pediatric Moyamoya Disease: Risk Factors and Clinical Outcome.
    Choi JW; Chong S; Phi JH; Lee JY; Kim HS; Chae JH; Lee J; Kim SK
    World Neurosurg; 2020 Apr; 136():e158-e164. PubMed ID: 31870818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Revascularization Surgery in Patients with Ischemic-Type Moyamoya Disease: Predictors for Postoperative Stroke and Long-Term Outcomes.
    Yu L; Ma L; Huang Z; Shi Z; Wang R; Zhao Y; Zhang D
    World Neurosurg; 2019 Aug; 128():e582-e596. PubMed ID: 31059856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Direct Anastomosis Using Occipital Artery for Additional Revascularization in Moyamoya Disease After Combined Superficial Temporal Artery-Middle Cerebral Artery and Indirect Bypass.
    Kazumata K; Kamiyama H; Saito H; Maruichi K; Ito M; Uchino H; Nakayama N; Kuroda S; Houkin K
    Oper Neurosurg (Hagerstown); 2017 Apr; 13(2):213-223. PubMed ID: 28927214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Features, Surgical Treatment, and Long-Term Outcome in Elderly Patients with Moyamoya Disease.
    Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang R; Zhang Y; Zhang D; Zhao J
    World Neurosurg; 2017 Apr; 100():459-466. PubMed ID: 28132922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topographic changes in cerebral blood flow and reduced white matter integrity in the first 2 weeks following revascularization surgery in adult moyamoya disease.
    Kazumata K; Tha KK; Uchino H; Shiga T; Shichinohe H; Ito M; Nakayama N; Abumiya T
    J Neurosurg; 2017 Aug; 127(2):260-269. PubMed ID: 27588593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a risk scoring model for postoperative adult moyamoya disease.
    Kim M; Park W; Chung Y; Lee SU; Park JC; Kwon DH; Ahn JS; Lee S
    J Neurosurg; 2021 May; 134(5):1505-1514. PubMed ID: 32384266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Optimum Operative Time of Revascularization for Patients with Moyamoya Disease Following Acute Onset.
    Xu S; Zhang J; Wang S; Li Z; Xiong Z; Wu X; Xin C; Wang H; Wang Y; Chen J
    World Neurosurg; 2018 Jun; 114():e412-e416. PubMed ID: 29530705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical clinical use of dynamic susceptibility contrast magnetic resonance imaging for the surgical treatment of moyamoya disease.
    Ishii Y; Nariai T; Tanaka Y; Mukawa M; Inaji M; Maehara T; Ohno K
    Neurosurgery; 2014 Mar; 74(3):302-9. PubMed ID: 24335813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivy sign: a diagnostic and prognostic biomarker for pediatric moyamoya.
    Montaser AS; Lalgudi Srinivasan H; Staffa SJ; Zurakowski D; Slingerland AL; Orbach DB; Hausman-Kedem M; Roth J; Smith ER
    J Neurosurg Pediatr; 2022 Apr; 29(4):458-466. PubMed ID: 34972077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.